Even if it is gaining the attention, Its momentum got killed by increasing AS to 300B which certainly points me to think that RS is imminent, sooner or later. As far as going to NASDAQ is concerned, under the current conditions it is impossible.
Next about the Phase II trials in March, lets hope that they go to the trial so that SP increases and every shareholder gets some profit. But in many instances I have seen that reality is too far away from the assumptions we shareholders make. March is too far and we will see what happens that time.
News 
Market Data 
Discover 
AI
